重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2014年
17期
2116-2118
,共3页
舒芙蓉%秦玉%曾媛%糜漫天
舒芙蓉%秦玉%曾媛%糜漫天
서부용%진옥%증원%미만천
大豆甙元%肥胖%心血管疾病
大豆甙元%肥胖%心血管疾病
대두대원%비반%심혈관질병
daidzein%obesity%cardiovascular-disease
目的:探讨大豆甙元对超重并肥胖人群的心血管疾病危险因素的影响。方法采用随机对照临床试验,从重庆市某三甲医院筛选80例体质量指数(BMI)>24 kg/m2的高胆固醇血症患者为受试对象,分为试验组和对照组,每组40例。试验组每日服用含80 mg大豆甙元的大豆分离蛋白粉5 g,对照组服用不含大豆异黄酮的大豆分离蛋白粉5 g,干预时间为6个月。服用前后测定心血管疾病危险因素相关指标。结果干预后试验组BMI下降,下降率为3.81%,自身干预前后比较差异有统计学意义(P<0.01);血清中总胆固醇(TC)下降,下降率为10.11%,自身干预前后比较差异有统计学意义(P<0.01),与对照组比较差异有统计学意义(P<0.05);糖化血红蛋白(HbA1c)下降,下降率为13.91%,自身干预前后比较差异有统计学意义(P<0.01),与对照组比较差异有统计学意义(P<0.05);血糖(Glu)下降,下降率为0.76%,自身干预前后比较差异有统计学意义(P<0.01)。血常规、肝功能、肾功等安全性指标干预前后均无明显改变。结论大豆甙元能降低高胆固醇血症患者 BMI、TC、HbA1c、Glu等心血管疾病危险因素。
目的:探討大豆甙元對超重併肥胖人群的心血管疾病危險因素的影響。方法採用隨機對照臨床試驗,從重慶市某三甲醫院篩選80例體質量指數(BMI)>24 kg/m2的高膽固醇血癥患者為受試對象,分為試驗組和對照組,每組40例。試驗組每日服用含80 mg大豆甙元的大豆分離蛋白粉5 g,對照組服用不含大豆異黃酮的大豆分離蛋白粉5 g,榦預時間為6箇月。服用前後測定心血管疾病危險因素相關指標。結果榦預後試驗組BMI下降,下降率為3.81%,自身榦預前後比較差異有統計學意義(P<0.01);血清中總膽固醇(TC)下降,下降率為10.11%,自身榦預前後比較差異有統計學意義(P<0.01),與對照組比較差異有統計學意義(P<0.05);糖化血紅蛋白(HbA1c)下降,下降率為13.91%,自身榦預前後比較差異有統計學意義(P<0.01),與對照組比較差異有統計學意義(P<0.05);血糖(Glu)下降,下降率為0.76%,自身榦預前後比較差異有統計學意義(P<0.01)。血常規、肝功能、腎功等安全性指標榦預前後均無明顯改變。結論大豆甙元能降低高膽固醇血癥患者 BMI、TC、HbA1c、Glu等心血管疾病危險因素。
목적:탐토대두대원대초중병비반인군적심혈관질병위험인소적영향。방법채용수궤대조림상시험,종중경시모삼갑의원사선80례체질량지수(BMI)>24 kg/m2적고담고순혈증환자위수시대상,분위시험조화대조조,매조40례。시험조매일복용함80 mg대두대원적대두분리단백분5 g,대조조복용불함대두이황동적대두분리단백분5 g,간예시간위6개월。복용전후측정심혈관질병위험인소상관지표。결과간예후시험조BMI하강,하강솔위3.81%,자신간예전후비교차이유통계학의의(P<0.01);혈청중총담고순(TC)하강,하강솔위10.11%,자신간예전후비교차이유통계학의의(P<0.01),여대조조비교차이유통계학의의(P<0.05);당화혈홍단백(HbA1c)하강,하강솔위13.91%,자신간예전후비교차이유통계학의의(P<0.01),여대조조비교차이유통계학의의(P<0.05);혈당(Glu)하강,하강솔위0.76%,자신간예전후비교차이유통계학의의(P<0.01)。혈상규、간공능、신공등안전성지표간예전후균무명현개변。결론대두대원능강저고담고순혈증환자 BMI、TC、HbA1c、Glu등심혈관질병위험인소。
Objective To investigate the effects of daidzein on the risk factors of cardiovascular disease(CVD)in overweight and obesity population.Methods Using the randomized controlled clinical trial,80 hypercholesterolemia patients with BMI>24 kg/m2 were screened as the study subjects from a class 3A hospital in Chongqing and randomly divided into the experimental group and the control group,40 cases in each group.The experimental group took isolated soy protein powder 5 g containing daidzein 80 mg every day and the control group only took isolated soy protein powder 5 g without containing isoflavones.The intervention time was 6 months.The CVD related risk factors and safety indexes were assessed before and after intervention.Results After 6-month in-tervention,BMI was decreased with the descent rate of 3.81%,the difference between before and after self intervention had statisti-cal significance(P<0.01);serum total cholesterol(TC)was decreased with the descent rate of 10.11%,the difference between be-fore and after self intervention had statistical significance(P<0.01),compared with the control group,the difference had statistical significance(P<0.05);glycated hemoglobin(HbA1c)was decreased with the descent rate of 13.91%,the difference between be-fore and after self intervention had statistical significance(P<0.01),compared with the control group,the difference had statistical significance(P<0.05);blood glucose(Glu)was decreased with the descent rate of 0.76%,the difference between before and after self intervention had statistical significance(P<0.01).The safety indexes in blood routine,liver function and renal function had no obvious changes before and after intervention.Conclusion Daidzein could decrease the CVD risk factors,such as BMI,TC,HbA1c and Glu.